UTHR
United Therapeutics·NASDAQ
--
--(--)
--
--(--)
8.38 / 10
Outperform
Analyst sentiment is highly bullish: 6 of 7 analysts rate Buy/Strong Buy, with win rates up to 100% and an 8.86 weighted rating. Fund‑flow score 7.91 shows strong inflows across most size segments, offset only by a slight extra‑large outflow, supporting a positive outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
43%
Buy
43%
Hold
0%
Sell
0%
Strong Sell
0%
Andreas ArgyridesBuy
Date2026-02-26
InstitutionOppenheimer
Times predicted2
Historical Win Rate100.0%
Andrew S. FeinStrong Buy
Ashwani VermaStrong Buy
Benjamin BurnettNeutral
Joseph ThomeStrong Buy
What is the market sentiment for UTHR?
- UTHR holds a Bullish analyst rating, with 43% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.38/10 (Outperform).
